The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of valproic acid as a histone deacetylase inhibitor in combination with S-1 on advanced pancreatobiliary tract cancers: Clinical study phases I and II.
Shuichi Iwahashi
No relevant relationships to disclose
Mitsuo Shimada
Research Funding - Taiho Pharmaceutical
Toru Utsunomiya
Research Funding - Taiho Pharmaceutical
Yuji Morine
No relevant relationships to disclose
Satoru Imura
No relevant relationships to disclose
Tetsuya Ikemoto
No relevant relationships to disclose
Yusuke Arakawa
No relevant relationships to disclose
Mami Kanamoto
No relevant relationships to disclose
Yu Saito
No relevant relationships to disclose